Healthcare, Regulatory and Reimbursement Landscape – US

Feb. 15, 2012 - PRLog -- The US is the third largest populated country in the world, with a population of around 310 million in 2010. The available data for the age distribution of the US confirms that the population share in the age groups of 0 - 19 and 20 - 59 years declined from 2005 to 2010. This represents a decline in the population of the working age. The population share in the age group of 60 years and above increased from 16.8% to 18.4% from 2005 to 2010. The share of population aged 60 years and above is increasing and is projected to reach 75.8 million (22.2%) by 2020. The elderly population of the US is increasing at a significant rate due to higher life expectancy, better healthcare facilities and strong financial support for the elderly population by the US government.

The population of the US is increasing due to:
•   People immigrating for studies and jobs: the net number of migrants increased from 2.8 to 4.3 per 1,000 populations during 2009 - 2010.
•   The birth rate at 13.8 per 1,000 populations was higher than the death rate at 8.4 per 1,000 populations in 2010. In 2001, the birth rate was 14.1 and the death rate was 8.5 per 1,000 populations.

The pharmaceutical market in the US was $329 billion in 2010 and is projected to reach $505 billion in 2020 with a Compound Annual Growth Rate (CAGR) of 4.4%.The pharmaceutical market in the US is driven by:
•   Strong patent laws for branded medicines
•   High Research and Development (R&D) expenditure
•   High public healthcare expenditure by Centers for Medicare and Medicaid Services (CMS)
•   Affordability for purchasing of high cost medicines
•   Advertisement of prescription drugs to the general public (Direct-to-Customer: DTC)
•   Sedentary lifestyle leading to high chronic disease burden in the US
•   Transparent, highly regulated guideline and easy online accessibility of regulatory body

For Sample Pages, please click or add the below link to your browser:
http://www.globaldata.com/ReportStore/RequestSamplePages....


The size of the medical device market was $123.9 billion in 2010. The market is projected to reach $220.5 billion by 2020 with a projected CAGR of 5.5%. The orthopedic devices (16.2%), in-vitro diagnostics (15.1%), cardiovascular devices (12.1%) and ophthalmic devices (9.4%) were the major segments in the medical devices market in 2010. The medical device market in the US is driven by:
•   Introduction of healthcare reform bill in 2010. This will expand medical coverage that creates new patient pools for medical device industries
•   Introduction of insurance reforms that make healthcare insurance mandatory and subsidized for low and middle income people
•   Innovation of cost effective medical devices.
•   Increasing awareness in patients and physicians toward early diagnosis of chronic diseases

Industry analysis specialist GlobalData, has released its new report, “Healthcare, Regulatory and Reimbursement Landscape - US”. The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of the US. It identifies the key trends in the healthcare market of the US and provides insights on the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the US. Most importantly, the report provides valuable insights on the trends and segmentation of pharmaceutical and medical devices market. This report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData’s team of industry experts.

For further details, please click or add the below link to your browser:
http://www.globaldata.com/ReportStore/Report.aspx?ID=Heal...


Visit our report store: http://www.globaldata.com/reportstore

For more details contact:
pressreleases@globaldata.com
           
North America:    +1 646 395 5477
Europe:        +44 207 753 4299
           +44 1204 543 533
Asia Pacific:       +91 40 6616 6782

# # #

GlobalData is a global market intelligence services company providing information research and analysis products and services.